{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T18:29:34Z","timestamp":1778178574001,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wound Healing Foundation 3M Fellowship Award"},{"name":"Plastic Surgery Foundation Translational Research Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cutaneous wounds in patients with diabetes exhibit impaired healing due to physiological impediments and conventional care options are severely limited. Multipotent stromal cells (MSCs) have been touted as a powerful new therapy for diabetic tissue repair owing to their trophic activity and low immunogenicity. However, variations in sources and access are limiting factors for broader adaptation and study of MSC-based therapies. Amniotic fluid presents a relatively unexplored source of MSCs and one with wide availability. Here, we investigate the potential of amniotic fluid-derived multipotent stromal cells (AFMSCs) to restore molecular integrity to diabetic wounds, amend pathology and promote wound healing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We obtained third trimester amniotic fluid from term cesarean delivery and isolated and expanded MSCs in vitro. We then generated 10\u00a0mm wounds in Lepr<jats:sup>db\/db<\/jats:sup> diabetic mouse skin, and splinted them open to allow for humanized wound modeling. Immediately after wounding, we applied AFMSCs topically to the sites of injuries on diabetic mice, while media application only, defined as vehicle, served as controls. Post-treatment, we compared healing time and molecular and cellular events of AFMSC-treated, vehicle-treated, untreated diabetic, and non-diabetic wounds. A priori statistical analyses measures determined significance of the data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Average time to wound closure was approximately 19\u00a0days in AFMSC-treated diabetic wounds. This was significantly lower than the vehicle-treated diabetic wounds, which required on average 27.5\u00a0days to heal (p\u2009&lt;\u20090.01), and most similar to time of closure in wild type untreated wounds (an average of around 18\u00a0days). In addition, AFMSC treatment induced changes in the profiles of macrophage polarizing cytokines, resulting in a change in macrophage composition in the diabetic wound bed. We found no evidence of AFMSC engraftment or biotherapy induced immune response.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Treatment of diabetic wounds using amniotic fluid-derived MSCs encourages cutaneous tissue repair through affecting inflammatory cell behavior in the wound site. Since vehicle-treated diabetic wounds did not demonstrate accelerated healing, we determined that AFMSCs were therapeutic through their paracrine activities. Future studies should be aimed towards validating our observations through further examination of the paracrine potential of AFMSCs. In addition, investigations concerning safety and efficacy of this therapy in clinical trials should be pursued.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-020-02674-5","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T21:03:31Z","timestamp":1609967011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Amniotic fluid-derived multipotent stromal cells drive diabetic wound healing through modulation of macrophages"],"prefix":"10.1186","volume":"19","author":[{"given":"Bibi S.","family":"Subhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Monas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8302-8225","authenticated-orcid":false,"given":"Piul S.","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"2674_CR1","unstructured":"National Diabetes Statistics Report, 2020. Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA. https:\/\/www.cdc.gov\/diabetes\/data\/statistics\/statistics-report.html. Accessed 19 May 2020."},{"key":"2674_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.avsg.2015.11.025","volume":"33","author":"CW Hicks","year":"2016","unstructured":"Hicks CW, Selvarajah S, Mathioudakis N, Sherman RE, Hines KF, Black JH 3rd, et al. Burden of infected diabetic foot ulcers on hospital admissions and costs. Ann Vasc Surg. 2016;33:149\u201358.","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"2674_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCRESAHA.117.306306","volume":"117","author":"C Sanina","year":"2015","unstructured":"Sanina C, Hare JM. Mesenchymal stem cells as a biological drug for heart disease: where are we with cardiac cell-based therapy? Circ Res. 2015;117(3):229\u201333.","journal-title":"Circ Res"},{"key":"2674_CR4","doi-asserted-by":"publisher","first-page":"3945672","DOI":"10.1155\/2019\/3945672","volume":"2019","author":"MP de Miguel","year":"2019","unstructured":"de Miguel MP, Prieto I, Moratilla A, Arias J, Aller MA. Mesenchymal stem cells for liver regeneration in liver failure: from experimental models to clinical trials. Stem Cells Int. 2019;2019:3945672.","journal-title":"Stem Cells Int"},{"issue":"21\u201322","key":"2674_CR5","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1089\/ten.tea.2018.0371","volume":"25","author":"SK George","year":"2019","unstructured":"George SK, Abolbashari M, Kim TH, Zhang C, Allickson J, Jackson JD, et al. Effect of human amniotic fluid stem cells on kidney function in a model of chronic kidney disease. Tissue Eng Part A. 2019;25(21\u201322):1493\u2013503.","journal-title":"Tissue Eng Part A"},{"issue":"2","key":"2674_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.15283\/ijsc16053","volume":"9","author":"K-H Han","year":"2016","unstructured":"Han K-H, Kim A-K, Kim D-I. Therapeutic potential of human mesenchymal stem cells for treating ischemic limb diseases. Int J Stem Cells. 2016;9(2):163\u20138.","journal-title":"Int J Stem Cells"},{"key":"2674_CR7","doi-asserted-by":"publisher","first-page":"602597","DOI":"10.1155\/2015\/602597","volume":"2015","author":"P Rowart","year":"2015","unstructured":"Rowart P, Erpicum P, Detry O, Weekers L, Gr\u00e9goire C, Lechanteur C, et al. Mesenchymal stromal cell therapy in ischemia\/reperfusion injury. J Immunol Res. 2015;2015:602597.","journal-title":"J Immunol Res"},{"key":"2674_CR8","doi-asserted-by":"publisher","first-page":"6901983","DOI":"10.1155\/2018\/6901983","volume":"2018","author":"MS Hu","year":"2018","unstructured":"Hu MS, Borrelli MR, Lorenz HP, Longaker MT, Wan DC. Mesenchymal stromal cells and cutaneous wound healing: a comprehensive review of the background, role, and therapeutic potential. Stem Cells Int. 2018;2018:6901983.","journal-title":"Stem Cells Int"},{"issue":"1","key":"2674_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2337\/db18-0232","volume":"68","author":"PS Rabbani","year":"2019","unstructured":"Rabbani PS, Soares MA, Hameedi SG, Kadle RL, Mubasher A, Kowzun M, et al. Dysregulation of Nrf2\/Keap1 redox pathway in diabetes affects multipotency of stromal cells. Diabetes. 2019;68(1):141\u201355.","journal-title":"Diabetes"},{"key":"2674_CR10","doi-asserted-by":"publisher","first-page":"107836","DOI":"10.1155\/2012\/107836","volume":"2012","author":"MG Roubelakis","year":"2012","unstructured":"Roubelakis MG, Trohatou O, Anagnou NP. Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int. 2012;2012:107836.","journal-title":"Stem Cells Int"},{"issue":"3","key":"2674_CR11","first-page":"147","volume":"6","author":"M Baghaban Eslaminejad","year":"2012","unstructured":"Baghaban Eslaminejad M, Jahangir S. Amniotic fluid stem cells and their application in cell-based tissue regeneration. Int J Fertil Steril. 2012;6(3):147\u201356.","journal-title":"Int J Fertil Steril"},{"issue":"1","key":"2674_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13287-017-0582-6","volume":"8","author":"R Moraghebi","year":"2017","unstructured":"Moraghebi R, Kirkeby A, Chaves P, R\u00f6nn RE, Sitnicka E, Parmar M, et al. Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications. Stem Cell Res Ther. 2017;8(1):190.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"2674_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1515\/jpm-2015-0152","volume":"44","author":"BK Young","year":"2016","unstructured":"Young BK, Chan MK, Liu L, Basch RS. Amniotic fluid as a source of multipotent cells for clinical use. J Perinat Med. 2016;44(3):333\u20137.","journal-title":"J Perinat Med"},{"key":"2674_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4172\/2157-7013.1000269","volume":"8","author":"A Larson","year":"2017","unstructured":"Larson A, Gallicchio V. Amniotic derived stem cells: role and function in regenerative medicine. J Cell Sci Ther. 2017;8:3.","journal-title":"J Cell Sci Ther"},{"issue":"3","key":"2674_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ajog.2015.12.061","volume":"214","author":"M Dziadosz","year":"2016","unstructured":"Dziadosz M, Basch RS, Young BK. Human amniotic fluid: a source of stem cells for possible therapeutic use. Am J Obstet Gynecol. 2016;214(3):321\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"2674_CR16","doi-asserted-by":"publisher","first-page":"11560","DOI":"10.1038\/srep11560","volume":"5","author":"Q Sun","year":"2015","unstructured":"Sun Q, Li F, Li H, Chen R-H, Gu Y-Z, Chen Y, et al. Amniotic fluid stem cells provide considerable advantages in epidermal regeneration: B7H4 creates a moderate inflammation microenvironment to promote wound repair. Sci Rep. 2015;5:11560.","journal-title":"Sci Rep"},{"issue":"9","key":"2674_CR17","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/term.2914","volume":"13","author":"C Brown","year":"2019","unstructured":"Brown C, McKee C, Bakshi S, Walker K, Hakman E, Halassy S, et al. Mesenchymal stem cells: cell therapy and regeneration potential. J Tissue Eng Regen Med. 2019;13(9):1738\u201355.","journal-title":"J Tissue Eng Regen Med"},{"key":"2674_CR18","first-page":"85","volume-title":"Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods in cell biology","author":"L Perin","year":"2008","unstructured":"Perin L, Sedrakyan S, Da Sacco S, De Filippo R. Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods in cell biology, vol. 86. USA: Academic Press; 2008. p. 85\u201399."},{"issue":"1","key":"2674_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/147323000903700112","volume":"37","author":"Q You","year":"2009","unstructured":"You Q, Tong X, Guan Y, Zhang D, Huang M, Zhang Y, et al. The biological characteristics of human third trimester amniotic fluid stem cells. J Int Med Res. 2009;37(1):105\u201312.","journal-title":"J Int Med Res"},{"issue":"7","key":"2674_CR20","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/stem.2553","volume":"35","author":"SP Loukogeorgakis","year":"2017","unstructured":"Loukogeorgakis SP, De Coppi P. Concise review: amniotic fluid stem cells: the known, the unknown, and potential regenerative medicine applications. Stem Cells. 2017;35(7):1663\u201373.","journal-title":"Stem Cells"},{"issue":"10","key":"2674_CR21","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1038\/mt.2012.117","volume":"20","author":"D Moschidou","year":"2012","unstructured":"Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, et al. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther. 2012;20(10):1953\u201367.","journal-title":"Mol Ther"},{"issue":"1","key":"2674_CR22","doi-asserted-by":"publisher","first-page":"8126","DOI":"10.1038\/s41598-019-44572-x","volume":"9","author":"F Vlahova","year":"2019","unstructured":"Vlahova F, Hawkins KE, Ranzoni AM, Hau K-L, Sagar R, De Coppi P, et al. Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A. Sci Rep. 2019;9(1):8126.","journal-title":"Sci Rep"},{"issue":"10","key":"2674_CR23","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1517\/14712598.2011.587800","volume":"11","author":"PAB Klemmt","year":"2011","unstructured":"Klemmt PAB, Vafaizadeh V, Groner B. The potential of amniotic fluid stem cells for cellular therapy and tissue engineering. Exp Opin Biol Ther. 2011;11(10):1297\u2013314.","journal-title":"Exp Opin Biol Ther"},{"issue":"3","key":"2674_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ajog.2018.05.035","volume":"219","author":"CD Dolin","year":"2018","unstructured":"Dolin CD, Chan MK, Basch RS, Young BK. Human term amniotic fluid: a novel source of stem cells for regenerative medicine. Am J Obstet Gynecol. 2018;219(3):308\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2674_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.5999\/aps.2013.40.5.496","volume":"40","author":"JD Yang","year":"2013","unstructured":"Yang JD, Choi DS, Cho YK, Kim TK, Lee JW, Choi KY, et al. Effect of amniotic fluid stem cells and amniotic fluid cells on the wound healing process in a white rat model. Arch Plast Surg. 2013;40(5):496\u2013504.","journal-title":"Arch Plast Surg"},{"issue":"6","key":"2674_CR26","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1089\/scd.2009.0138","volume":"19","author":"BS Yoon","year":"2009","unstructured":"Yoon BS, Moon J-H, Jun EK, Kim J, Maeng I, Kim JS, et al. Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. Stem Cells Dev. 2009;19(6):887\u2013902.","journal-title":"Stem Cells Dev"},{"issue":"5","key":"2674_CR27","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1172\/JCI32169","volume":"117","author":"H Brem","year":"2007","unstructured":"Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117(5):1219\u201322.","journal-title":"J Clin Invest"},{"issue":"4","key":"2674_CR28","first-page":"485","volume":"12","author":"RD Galiano","year":"2004","unstructured":"Galiano RD, Michaels JT, Dobryansky M, Levine JP, Gurtner GC. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen Off Publ Wound Heal Soc Eur Tissue Repair Soc. 2004;12(4):485\u201392.","journal-title":"Wound Repair Regen Off Publ Wound Heal Soc Eur Tissue Repair Soc"},{"issue":"5","key":"2674_CR29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0895-4356(01)00512-1","volume":"55","author":"DJ Margolis","year":"2002","unstructured":"Margolis DJ, Bilker W, Boston R, Localio R, Berlin JA. Statistical characteristics of area under the receiver operating characteristic curve for a simple prognostic model using traditional and bootstrapped approaches. J Clin Epidemiol. 2002;55(5):518\u201324.","journal-title":"J Clin Epidemiol"},{"key":"2674_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.04.001","volume":"132","author":"PS Rabbani","year":"2017","unstructured":"Rabbani PS, Zhou A, Borab ZM, Frezzo JA, Srivastava N, More HT, et al. Novel lipoproteoplex delivers Keap1 siRNA based gene therapy to accelerate diabetic wound healing. Biomaterials. 2017;132:1\u201315.","journal-title":"Biomaterials"},{"issue":"5","key":"2674_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1524-475X.2007.00273.x","volume":"15","author":"J Michaels","year":"2007","unstructured":"Michaels J, Churgin SS, Blechman KM, Greives MR, Aarabi S, Galiano RD, et al. db\/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Repair Regen. 2007;15(5):665\u201370.","journal-title":"Wound Repair Regen"},{"issue":"8","key":"2674_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.amjmed.2003.06.006","volume":"115","author":"DJ Margolis","year":"2003","unstructured":"Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Diabetic neuropathic foot ulcers: predicting which ones will not heal. Am J Med. 2003;115(8):627\u201331.","journal-title":"Am J Med"},{"issue":"2","key":"2674_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1067-1927.2004.012207.x","volume":"12","author":"DJ Margolis","year":"2004","unstructured":"Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. The accuracy of venous leg ulcer prognostic methods in a wound care system. Wound Repair Regen. 2004;12(2):163\u20138.","journal-title":"Wound Repair Regen"},{"issue":"4","key":"2674_CR34","doi-asserted-by":"publisher","first-page":"e94188","DOI":"10.1371\/journal.pone.0094188","volume":"9","author":"MR Fernando","year":"2014","unstructured":"Fernando MR, Reyes JL, Iannuzzi J, Leung G, McKay DM. The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages. PLoS ONE. 2014;9(4):e94188.","journal-title":"PLoS ONE"},{"key":"2674_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3389\/fphys.2018.00419","volume":"9","author":"P Krzyszczyk","year":"2018","unstructured":"Krzyszczyk P, Schloss R, Palmer A, Berthiaume F. The role of macrophages in acute and chronic wound healing and interventions to promote pro-wound healing phenotypes. Front Physiol. 2018;9:419.","journal-title":"Front Physiol"},{"key":"2674_CR36","unstructured":"United States National Library of Medicine. Clinicaltrials.gov. http:\/\/clinicaltrials.gov. Accessed 19 May 2020."},{"issue":"7","key":"2674_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/wound.2017.0761","volume":"7","author":"J Larouche","year":"2018","unstructured":"Larouche J, Sheoran S, Maruyama K, Martino MM. Immune regulation of skin wound healing: mechanisms and novel therapeutic targets. Adv Wound Care (New Rochelle). 2018;7(7):209\u201331.","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"10","key":"2674_CR38","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS ONE. 2012;7(10):e47559.","journal-title":"PLoS ONE"},{"issue":"6","key":"2674_CR39","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/aps.2013.50","volume":"34","author":"X Wei","year":"2013","unstructured":"Wei X, Yang X, Han Z-p, Qu F-f, Shao L, Shi Y-f. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013;34(6):747\u201354.","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"2674_CR40","doi-asserted-by":"publisher","first-page":"e41105","DOI":"10.1371\/journal.pone.0041105","volume":"7","author":"S-W Kim","year":"2012","unstructured":"Kim S-W, Zhang H-Z, Guo L, Kim J-M, Kim MH. Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD\/SCID mice through high angiogenic and engraftment capabilities. PLoS ONE. 2012;7(7):e41105.","journal-title":"PLoS ONE"},{"key":"2674_CR41","unstructured":"National Center for Health Statistics: Births\u2014Method of Delivery. Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA. https:\/\/www.cdc.gov\/nchs\/fastats\/delivery.htm. Accessed 19 May 2020."},{"issue":"2","key":"2674_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12272-012-0207-7","volume":"35","author":"S Joo","year":"2012","unstructured":"Joo S, Ko IK, Atala A, Yoo JJ, Lee SJ. Amniotic fluid-derived stem cells in regenerative medicine research. Arch Pharmacal Res. 2012;35(2):271\u201380.","journal-title":"Arch Pharmacal Res"},{"key":"2674_CR43","doi-asserted-by":"publisher","first-page":"462179","DOI":"10.1155\/2013\/462179","volume":"2013","author":"M Yang","year":"2013","unstructured":"Yang M, Sheng L, Zhang TR, Li Q. Stem cell therapy for lower extremity diabetic ulcers: where do we stand? Biomed Res Int. 2013;2013:462179.","journal-title":"Biomed Res Int"},{"key":"2674_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","volume":"6","author":"FO Martinez","year":"2014","unstructured":"Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13.","journal-title":"F1000Prime Rep"},{"issue":"4","key":"2674_CR45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00011-020-01328-y","volume":"69","author":"GV Ganesh","year":"2020","unstructured":"Ganesh GV, Ramkumar KM. Macrophage mediation in normal and diabetic wound healing responses. Inflamm Res. 2020;69(4):347\u201363.","journal-title":"Inflamm Res"},{"issue":"1","key":"2674_CR46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nbt1274","volume":"25","author":"P De Coppi","year":"2007","unstructured":"De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25(1):100\u20136.","journal-title":"Nat Biotechnol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02674-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-020-02674-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02674-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T18:12:59Z","timestamp":1674843179000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02674-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2674"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02674-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}